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The molecular mechanisms involved in induced pluripotent stem cells (iPSCs) generation are poorly understood.
The cell death machinery of apoptosis-inducing caspases have been shown to facilitate the process of iPSCs
reprogramming. However, the eﬀect of other cell death processes, such as programmed necrosis (necroptosis),
on iPSCs induction has not been studied. In this study, we investigated the role of receptor-interacting protein
kinase 3 (RIP3), an essential regulator of necroptosis, in reprogramming mouse embryonic ﬁbroblast cells
(MEFs) into iPSCs. RIP3 was found to be upregulated in iPSCs compared to MEFs. Deletion of RIP3 dramatically
suppressed the reprogramming of iPSCs (~82%). RNA-seq analysis and qRT-PCR showed that RIP3 KO MEFs
expressed lower levels of genes that control cell cycle progression and cell division and higher levels of extra-
cellular matrix-regulating genes. The growth rate of RIP3 KO MEFs was signiﬁcantly slower than WT MEFs.
These ﬁndings can partially explain the inhibitory eﬀects of RIP3 deletion on iPSCs generation and show for the
ﬁrst time that the necroptosis kinase RIP3 plays an important role in iPSC reprogramming. In contrast to RIP3,
the kinase and scaﬀolding functions of RIPK1 appeared to have distinct eﬀects on reprogramming.
1. Introduction
Reprogramming of diﬀerentiated cells into induced pluripotent stem
cells (iPSCs) can be achieved by ectopic expression of certain combi-
nations of transcription factors, such as Oct4, Sox2, Klf4, and c-Myc, or
Oct4, Sox2, Nanog, and Lin28 (Liu et al., 2014;Takahashi and
Yamanaka, 2006,2016;Yu et al., 2007;Zhao et al., 2009). Given that
iPSCs are molecularly and functionally similar to embryonic stem cells
(ESCs) and can be generated from patient somatic cells without de-
stroying human embryos, they hold great promise for the ﬁelds of re-
generative medicine, disease modeling, and drug discovery (Liu et al.,
2014;Takahashi and Yamanaka, 2006,2016;Trounson and DeWitt,
2016;Yu et al., 2007;Zhao et al., 2009). However, the mechanisms
underlying transcription factor-mediated reprogramming are still
poorly understood (Li et al., 2013;Smith et al., 2016;Takahashi and
Yamanaka, 2016).
Multiple factors contribute to the iPSCs reprogramming process
(Jaenisch and Young, 2008;Smith et al., 2016;Yamanaka,
2009;Yamanaka and Blau, 2010), which has been modeled as a sto-
chastic process that can be accelerated through both cell-division-rate-
dependent and cell-division-rate- independent manners (Hanna et al.,
2009;Smith et al., 2016). However, cell death pathways have not been
well studied in iPSCs reprogramming process. An interesting, yet sur-
prising, study by Li et al. showed that inhibition of caspase 3 or 8 in
human ﬁbroblast cells partially or completely, respectively, prevented
the induction of iPSCs, indicating that apoptotic caspases positively
regulate iPSCs reprogramming from human ﬁbroblasts (Li et al.,
2010a). Besides apoptosis, other cell death processes exist, such as
necrosis. Necrosis or necroptosis was considered for years to be an
unregulated accidental cell death process (Pasparakis and
Vandenabeele, 2015). However, later evidence proved that necrosis is
also a regulated and controlled form of cell death (Trichonas et al.,
2010; Pasparakis and Vandenabeele, 2015). Receptor interacting pro-
tein kinase 3 (RIPK3 or RIP3) is a central mediator of necroptosis and
has been shown to be involved in numerous pathological conditions
(Galluzzi et al., 2017;Murakami et al., 2012;Orozco and Oberst,
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2017;Trichonas et al., 2010;Weinlich et al., 2016). However, its role in
iPSC induction has not been studied thus far.
The incomplete understanding of the mechanisms underlying tran-
scription factor-mediated reprogramming limits our ability to further
enhance the eﬃciency of iPSC induction. Since previous work has
shown that caspases, which regularly promote cell death in adult cells,
actually promote iPSC induction, we wanted to investigate if this can be
expanded to other non-apoptotic cell death machinery. For this reason,
we investigated the eﬀect of the main necroptosis mediator RIP3 on the
process of transcription factor-mediated reprogramming of mouse em-
bryonic ﬁbroblast cells (MEFs) to iPSCs and its possible mechanisms.
2. Methods
Detailed methods are described in the supplementary information.
3. Results
3.1. Expression of RIP3 is upregulated in induced pluripotent stem cells
(iPSCs)
To examine the potential role of RIP3 in iPSCs reprogramming
process, we ﬁrst examined the expression of RIP3 at the protein level
using immunoblot analysis in mouse iPSCs (miPSCs) generated from
MEFs. We observed that the protein level of RIP3 was increased in
miPSCs compared to MEFs (Fig. 1A, B). Time course analysis during the
reprogramming process showed that the protein level of RIP3 was
gradually increased during the second half of the reprogramming pro-
cess (Fig. 1C, D). This indicates that RIP3, a key regulator of ne-
croptosis, might be involved in regulation of somatic cells reprogram-
ming to iPSCs.
Fig. 1. RIP3 is upregulated during the iPSCs reprogramming process. (A) Upper ﬁgure: Immunoblot analysis of RIP3 in MEFs and 3 diﬀerent MEFs-derived iPSCs
colonies (miPSCs) generated by the three transcription factors (Oct4, Sox2, Klf4; OSK) combined with the small molecule medium supplements. Ponceau S staining
was used to conﬁrm equal protein loading. Lower ﬁgure: Immunoblot analysis of RIP3 in the commercially available MEFs (#PMEF-CFL from Millipore) and the
commercially available miPSC (#iPS02M from ALSTEM) (B) Density values of RIP3 bands in the upper ﬁgure of (A) are graphically expressed. (C) Immunoblot
analysis of RIP3 in MEFs transduced with OSK and treated with the small molecule medium supplements. Transduced cells were analyzed for RIP3 at the indicated
time points after lentiviral transduction. Ponceau S staining was used to conﬁrm equal protein loading. (D) Density values of RIP3 bands in (C) are graphically
expressed. Data are means± SEM. *P < .05 and ***P < .001 from two-tailed Student's t-test.
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3.2. Deletion of RIP3 reduces iPSCs reprogramming eﬃciency
To investigate the eﬀect of RIP3 on iPSCs reprogramming, the ef-
ﬁciency of iPSCs colony formation was compared between RIP3 KO and
WT MEFs. The same number of MEF cells of each genotype were seeded
and then reprogrammed to iPSCs. The resulting iPSC colonies were
stained at day 15 with alkaline phosphatase (AP) and quantiﬁed for
reprogramming eﬃciency. Deletion of RIP3 dramatically decreased the
number of AP-positive iPSC colonies (~ 82% less colonies in RIP3 KO
compared to WT MEFs) (Fig. 2B, C), indicating that RIP3 plays a critical
role in facilitating the iPSCs reprogramming process. Knockout of RIP3
was veriﬁed by western blotting (Fig. 2A) and the pluripotency of the
resulting iPSCs was conﬁrmed by immunostaining with pluripotency
markers (Fig. 2D).
3.3. RIP3 KO MEFs display lower expression of cell cycle genes and a slower
proliferation rate compared to WT MEFs
To investigate the molecular mechanisms for the inhibitory eﬀect of
RIP3 deletion on iPSCs reprogramming, we performed whole
transcriptome expression analysis (RNA-seq) of passage 2 of WT and
RIP3 KO MEFs. The results showed that the gene expression proﬁle of
RIP3 KO MEFs was distinct from WT cells as expected with several
hundred genes changing>2 folds and 50 genes changing> 5 folds
(Fig. 3A). To better understand the RNA-Seq changes, gene ontology
(GO) analysis was performed revealing that cell cycle progression and
cell division were downregulated in RIP3 KO MEFs compared to WT
cells (Fig. 3B, C). We validated this by using quantitative RT-PCR of
select genes, such as cyclin-dependent kinase (CDK1), CDK6, cell divi-
sion cycle 6 (CDC6), and CDC7 (Fig. 3D). In addition, the expression
level of protein regulator of cytokinesis 1 (Prc1), epithelial cell trans-
forming 2 (Ect2), and aurora kinase A (Aurka), which function mainly
in cell division, was also decreased in RIP3 KO compared to WT MEFs
(Fig. 3E).
Proliferation rate of somatic cells aﬀects the eﬃciency of their re-
programming to iPSCs, with high proliferation rate being required for
reprogramming (Ruiz et al., 2011). Considering the RNA-seq results, we
assessed the proliferation of RIP3 KO MEFs. We observed that the
growth rate of RIP3 KO MEFs was signiﬁcantly lower than WT MEFs
(Fig. 3F, G). Furthermore, the growth rate of RIP3 KO MEFs during the
Fig. 2. Deletion of RIP3 suppresses iPSCs reprogramming. (A) Knockout (KO) of endogenous RIP3. Immunoblot analysis of RIP3 in WT and RIP3 KO MEFs. GAPDH
was detected as a loading control. (B) Frequency of AP-positive iPSCs colonies derived from RIP3 KO relative to those derived from WT MEFs at day 15 after
transduction. (C) Representative dishes of AP staining of iPSC colonies derived from MEFs in WT and RIP3 KO genotypes. (D) Characterization of RIP3 KO miPSCs.
Immunostaining patterns for OCT-4, SOX-2, DPPA-2, and SSEA-1. Data are means± SEM. *P < .05 from two-tailed Student's t-test.
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reprogramming process was also signiﬁcantly lower than WT MEFs
(Fig. 3H).
This link between RIP3 and cell proliferation explain, at least par-
tially, the mechanism by which deletion of RIP3 leads to suppression of
iPSCs reprogramming.
3.4. RIP3 KO MEFs express higher levels of extracellular matrix (ECM)
genes
Prior studies have suggested that the ECM is a barrier for iPSCs
reprogramming (Jiao et al., 2013). Interestingly, GO analysis of the
diﬀerentially expressed genes from the RNA-seq showed that genes
whose function is related to ECM were upregulated in RIP3 KO com-
pared to WT MEFs (Fig. 4A). qRT-PCR validation showed that the ex-
pression level of collagen type III alpha 1 chain (Col3a1), Col8a1,
Col12a1, and hyaluronan and proteoglycan link protein 1 (Hapln1),
whose functions are related to ECM, were increased in RIP3 KO com-
pared to WT MEFs (Fig. 4B). This novel link between RIP3 and ECM
could also partially explain the inhibitory eﬀects of deleting RIP3 on
iPSCs reprogramming.
Due to technical diﬃculties, we were not able to overexpress RIP3
in MEFs before and during reprogramming to assess whether this could
reverse the eﬀects observed in MEFs that are deﬁcient in RIP3.
4. Discussion
In this study, necroptotic RIP3 kinase is shown to play an important
role in reprogramming of somatic cells to iPSCs. RIP3 was upregulated
during iPSC induction and deletion of RIP3 led to a dramatic suppres-
sion of iPSCs induction. Mechanistically this could be explained, at least
partially, by the fact that RIP3 KO MEFs had lower expression levels of
cell cycle and cell division related genes, slower growth rate, and higher
expression of ECM related genes.
Cell death is a substantial component of homeostasis in multi-
cellular organisms. It is generally thought that apoptosis has a major
physiologic role during embryonic development, while necroptosis is
Fig. 3. Deletion of RIP3 leads to lower expression of cell cycle and cell division genes and a slower proliferation rate of MEFs. (A) Transcriptome expression analysis
(RNA-seq) of WT and RIP3 KO MEF cells. Heatmap displaying the diﬀerential gene expression patterns of passage 2 WT and RIP3 KO MEF cells. Genes displayed are
the top 1000 genes that showed statistical signiﬁcant diﬀerence based on fold changes of 2 or more and FDR adjusted P value< .05 between WT and RIP3 KO. (B)
Heatmap displaying the diﬀerential expression patterns of genes related to cell cycle progression and (C) cell division in passage 2 WT and RIP3 KO MEF cells. Cell
cycle progression and cell division and genes related to them are chosen from the results of GO term analysis of the diﬀerentially expressed genes between WT and
RIP3 KO MEF cells. (D) Validation of some cell cycle-related genes and (E) cell division-related genes identiﬁed in (B) and (C) by quantitative RT-PCR. (F) Growth
curve of passage 3 WT and RIP3 KO MEF cells. (G) EdU cell proliferation assay of passage 3 WT and RIP3 KO MEF cells. (H) Growth curve of passage 3 OSK-
transduced WT and RIP3 KO MEF cells during the reprogramming process as determined by trypan blue exclusion counting. Data are means± SEM. *P < .05,
**P < .01 from two-tailed Student's t-test.
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thought to be mainly involved in pathologic states (Berger et al.,
2014;Grootjans et al., 2017;Newton et al., 2004). Decreasing cell death
and increasing cell survival is known to enhance iPSCs reprogramming
(Jiang et al., 2016). Surprisingly, however, inhibition of caspase 3 and
caspase 8 in human ﬁbroblasts has been shown to partially or com-
pletely, respectively, prevent the induction of iPSCs (Li et al., 2010a).
This eﬀect was mediated through targeting of the retinoblastoma sus-
ceptibility (Rb) gene, which is a tumor suppressor gene that regulates
cell cycle progression, by caspase 3 and caspase 8 during reprogram-
ming (Li et al., 2010a).
Our study shows for the ﬁrst time that RIP3, a main regulator of the
other major cell death pathway (necroptosis), also aﬀects reprogram-
ming eﬃciency likely through eﬀects on genes that regulate cell cycle
progression and ECM. Few prior reports have looked at RIP3 eﬀects on
cellular proliferation. Elevated expression of RIP3 suppresses the
growth of vascular smooth muscle cells through inhibiting phosphoi-
nositide 3-kinase-Akt axis, while silencing RIP3 gene enhances serum-
and platelet-derived growth factor-induced cell proliferation (Li et al.,
2010b). Overexpression of RIP3 has been shown to inhibit the growth
of intrahepatic and lung tumors in vivo, although it did not aﬀect the
cell proliferation rate (Vucur et al., 2013;Yang et al., 2017). Similarly,
deleting RIP3 in acute myeloid leukemia (AML) cells did not sig-
niﬁcantly aﬀect the cell proliferation rate, but led to partial cellular
diﬀerentiation and decreased the colony formation ability of the cells
(Xin et al., 2017). Although opposite to some published reports in other
cell types, our ﬁndings that RIP3 deletion leads to slower MEFs growth
rate further conﬁrms the potential role of RIP3 as a cell growth
regulator. This role, however, seems to be cell type- and condition-
dependent. A proteome-wide analysis of RIP3-regulated phosphoryla-
tion sites in macrophages and MEFs isolated from wild type and Rip3
KO mice found that a large number of the identiﬁed phosphopeptides
were exclusive to macrophages or to MEFs, indicating that cell type-
speciﬁc function of RIP3 exists (Wu et al., 2012). Interestingly, many of
the RIP3-regulated phosphoproteins were functionally associated with
the cell cycle (Wu et al., 2012).
Stem cell and cell cycle machineries are intertwined and mechan-
isms controlling the cell cycle are an integral mechanistic part of the
pluripotent state of stem cells (Boward et al., 2016;Kareta et al.,
2015b). Cell cycle regulation is also critical for establishment as well as
maintenance of iPSCs (Boward et al., 2016;Ruiz et al., 2011), as evident
by multiple factors. First, there is a strong link between the proliferative
capacity of somatic cells and their ability to be reprogrammed (Boward
et al., 2016;Utikal et al., 2009). Rapid proliferation of the starting cell
population enhances the reprogramming and enriching for proliferating
cells increases reprogramming eﬃciency (Ghule et al., 2011;Kareta
et al., 2015b;Roccio et al., 2013;Ruiz et al., 2011). Second, cell cycle
genes are upregulated and cell cycle remodeling occurs early during
reprogramming (Boward et al., 2016;Cacchiarelli et al., 2015;Kareta
et al., 2015b;Ruiz et al., 2011). Third, cells with CDK inhibition become
refractive to reprogramming (Kawamura et al., 2009;Li et al.,
2009;Marión et al., 2009;Zhu et al., 2016) and ectopic expression of
CDK-cyclin complexes increases the reprogramming eﬃciency (Boward
et al., 2016;Ruiz et al., 2011). Lastly, reducing factors that antagonizes
cell division, such as Rb, Cyclin-dependent kinase inhibitors (CDKIs),
Fig. 4. Deletion of RIP3 leads to higher expression of extracellular matrix (ECM) genes in MEFs. (A) Heatmap displaying the diﬀerential expression patterns of genes
related to extracellular matrix in passage 2 WT and RIP3 KO MEF cells. Extracellular matrix and genes related to it are chosen from the results of GO term analysis of
the diﬀerentially expressed genes between WT and RIP3 KO MEF cells. (B) Validation of some extracellular matrix-related genes identiﬁed in (A) by quantitative RT-
PCR. Data are means± SEM. *P < .05, ***P < .001 from two-tailed Student's t-test.
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5
and p53 enhances reprogramming (Kareta et al., 2015a,b;Li et al.,
2012;Lin et al., 2014). Therefore, the reduced growth rate of RIP3 KO
MEFs and the downregulation of many cell cycle and cell division
genes, including CDKs, CDCs, and Aurka, in our study can largely ex-
plain the inhibitory eﬀect of RIP3 deletion on iPSCs reprogramming.
Furthermore, this novel link between RIP3 and cell cycle progression
sheds light on an important mechanism that can explain the eﬀect of
RIP3 on the growth of various cell types, as previously mentioned, and
might have other implications that require further studies.
Extracellular matrix (ECM) plays a role in iPSCs reprogramming.
Collagen has been shown to be a barrier for reprogramming MEFs to
iPSCs and downregulation of collagen gene expression can signiﬁcantly
improve the reprogramming eﬃciency (Jiao et al., 2013). The re-
lationship between RIP3 and extracellular matrix has not been widely
studied. One study showed that deletion of RIP3 reduces the levels of
ﬁbrosis and Col1a1 in the liver of a non-alcoholic steatohepatitis mouse
model (Gautheron et al., 2014). Our novel ﬁnding that RIP3 KO MEFs
express higher levels of ECM regulating genes than WT MEFs may, at
least partially, explain the results of reduced iPSCs reprogramming ef-
ﬁciency and provides a new insight regarding other functions of RIP3.
Importantly, previous studies have shown that ECM collagen inhibits
the growth and alter the cell cycle progression of various cancer cell
lines and skin ﬁbroblasts (Ivanov et al., 2007;Koohestani et al.,
2013;Rhudy and McPherson, 1988). This suggests that the increased
expression of ECM genes in RIP3 KO MEFs could reduce iPSCs repro-
gramming eﬃciency through aﬀecting the cell cycle progression and
cell proliferation, as we show in our results, rather than by a completely
independent mechanism.
Besides RIP3, Receptor Interacting Protein kinase 1 (RIP1) is an-
other key regulator of necroptosis, that can also promote cell survival
depending on the situation (Christoﬀerson et al., 2014). Similar to its
complex role in cell survival and death, it also appears to play a com-
plicated role in iPSCs induction. We observed that the protein level of
RIP1 was reduced in iPSCs compared to MEFs (S Fig. 1A, B), but during
reprogramming it mildly increased at day 4 after induction followed by
a gradual decrease as reprogramming progressed (S Fig. 1C, D). Dele-
tion of RIP1 showed that reprogramming eﬃciency of RIP1 KO MEFs
was similar to WT MEFs in half of the experiments and higher in an-
other half, leading to an overall statistically insigniﬁcant increase (S
Fig. 2). Furthermore, reprogramming eﬃciency of kinase dead RIP1
MEFs or RIP1 kinase inhibitor-treated WT MEFs was lower than WT
MEFs (S Fig. 1D, E). These results indicate that RIP1 plays a role in
iPSCs generation, but kinase and scaﬀolding functions of RIP1 have
distinct and maybe opposing eﬀects on this process. This complex result
on the role of RIP1 in iPSC reprogramming is not unlike the eﬀects seen
in cell death and survival (Christoﬀerson et al., 2014), and further
studies are needed to completely understand the eﬀect of RIP1 vs RIP3
on iPSCs reprogramming.
In summary, our results shed light on unknown functions of RIP3
and show for the ﬁrst time that the necroptosis-mediator RIP3 Kinase is
important for iPSCs reprogramming through, at least in part, cell cycle
and ECM regulation. This adds to our knowledge about the role of cell
death regulator in iPSC induction and improves our understanding of
this important and complicated process.
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